Similar to our findings, Kholmirzayev [24], who compared three different groups with different treatment regimens in patients with RA, reported that high RA disease activity was associated with high CRP and dyslipidemia and the severity of dyslipidemia impairment can be correlated to increased RA severity. This evidence concerns the gene CRP and metabolic syndrome.